Revenue | ₹3.85Cr |
Net Profits | ₹0.17Cr |
Net Profit Margins | -4.42% |
Beryl Drugs Ltd’s revenue fell -28.7% since last year same period to ₹3.85Cr in the Q3 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -25.39% fall in its revenue since last 3-months.
Beryl Drugs Ltd’s net profit fell -440% since last year same period to ₹0.17Cr in the Q3 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -1800% fall in its net profits since last 3-months.
Beryl Drugs Ltd’s net profit margin fell -576.88% since last year same period to -4.42% in the Q3 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -2378.44% fall in its net profit margins since last 3-months.
The revenue for Beryl Drugs Ltd in the Q3 results 2025 was ₹3.85Cr.
The net profit for Beryl Drugs Ltd in the Q3 results 2025 was ₹0.17Cr.
The net profit margin for Beryl Drugs Ltd in the Q3 results 2025 was -4.42%.
The revenue for Beryl Drugs Ltd in the Q3 results 2024 was ₹5.40Cr.
The net profit for Beryl Drugs Ltd in the Q3 results 2024 was ₹0.05Cr.
The net profit margin for Beryl Drugs Ltd in the Q3 results 2024 was 0.93%.